Jang HJ, Hostetter G, Macfarlane AW, Madaj Z, et al. A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy. Clin Cancer Res 2023;29:2052-2065.
PMID: 36928921